Circulating cell-free BRAF V600E during chemotherapy is associated with prognosis of children with Langerhans cell histiocytosis

Haematologica. 2020 Sep 1;105(9):e444-447. doi: 10.3324/haematol.2019.229187.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Histiocytosis, Langerhans-Cell* / diagnosis
  • Histiocytosis, Langerhans-Cell* / drug therapy
  • Humans
  • Mutation
  • Prognosis
  • Proto-Oncogene Proteins B-raf* / genetics

Substances

  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf